Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-13

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved the original application for methylphenidate hydrochloride (LA) from Teva Pharmaceuticals USA, Inc. as a long-acting generic stimulant. The product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate hydrochloride (LA) (Methylphenidate hydrochloride)

Snippet

ORIG AP for METHYLPHENIDATE HYDROCHLORIDE (LA) (METHYLPHENIDATE HYDROCHLORIDE)